Bladder Cancer
Conditions
Keywords
bladder cancer, transurethral resection of bladder tumors
Brief summary
The purpose of this study is to compare the use of two types of equipment during transurethral resection of bladder tumors (TURBT). The two types of surgical devices are: the monopolar loop electrocautery and the PlasmaKinetic (PK) Button Vaporization Electrode. These two devices do the same task but differ in the way they create electric current when removing cancerous tissue. The investigators hope to examine and compare the uses of these two surgical devices to see if any advantages do exist or whether they actually are similar. The goal of the study is to prove similarity in outcomes between the two techniques and analyze the outcomes resulting from each case.
Detailed description
This study will study the medical intervention used when bladder cancer patients present with a new or recurrent bladder tumor. Currently when patients report these tumors, they undergo a standard practice called transurethral resection of the bladder tumor (TURBT) in order to determine the stage of the cancer. This intervention, accomplished by looking through the urethra using an endoscope, is both diagnostic and potentially therapeutic. An adequately performed TURBT will provide the pathologist with enough tissue to provide tumor grade and stage information. Currently, TURBT is done using equipment called monopolar electrocautery which is in the form a 90-degree loop electrode. Although usually safe and sufficient, this technique can create technical challenges because it can be difficult to position the loop electrode in a dynamically changing cylindrical space (the bladder). Specifically, especially with larger bladder tumors, intraoperative bleeding can obscure visualization and result in incomplete tumor resection as well as inadequate sampling of the layers of the bladder needed to establish tumor stage. Furthermore, monopolar current can result in stimulation of a nerve (the obturator nerve) during resection of wall tumors, resulting in violent movement of the leg which can cause a potential bladder tear as well as possible (iliac) vessel injury. Conversely, a technique using bipolar energy, which has been available for many years, has been readily adopted for the surgical treatment of benign prostatic enlargement. The advantages of a bipolar electrical current include the direct return of electrical current to the loop rather than to a grounding pad placed on the patient's skin. This has the theoretical value of limiting the diffusion of electrical current, and therefore heat, to the surrounding tissue. A further refinement on bipolar energy has been the recent introduction of a piece of equipment called the PlasmaKinetic (PK) Button Vaporization electrode, which is currently approved by the Food and Drug Administration (FDA) for this indication. Coupling bipolar energy into the Button electrode would not only harness the benefits of less thermal spread but also would obviate the geometric challenges associated with loop electrodes during resection of bladder tumors. Procedural advantages would potentially include minimal bleeding, good visualization, and a reduction in the occurrence of the obturator reflex and concomitant bladder perforation. This study is a randomized double-arm trial examining the results of both techniques for bladder cancer TURBT procedures with a minimum of 120 patients at Emory. The purpose of this study is to measure the procedural (intraoperative), short term, as clinically indicated (4-6 weeks), and long-term (3 months) outcomes of TURBT using the PK Button when compared to traditional monopolar loop electrocautery. The goal of the study is to prove equivalence in outcomes between the two techniques.
Interventions
Standard monopolar electrocautery loop in transurethral resection of bladder tumors (TURBT)
PlasmaKinetic (PK) Button Vaporization Electrode in transurethral resection of bladder tumors (TURBT)
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with cystoscopically detected bladder tumors requiring TURBT * Patients with bladder tumors which are endoscopically resectable by surgeon's judgment with only one trip into the operating room.
Exclusion criteria
* Patients with clinical evidence of locally advanced, nodal, or metastatic bladder cancer * Patients with hydronephrosis secondary to bladder cancer * Patients with diffuse tumor throughout bladder that is deemed unresectable by surgeon
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Procedural Complications | Post-Intervention (Up to 30 Days) | The number of procedural complications describes the total number of post-operative bleeding, need for blood transfusion, bladder perforation, obturator nerve stimulation, catheterization time, or need for hospitalization or bladder irrigation events that occur within thirty days of the procedure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Disease Recurrence | Post-Intervention (Up to 4 Months) | The number of participants who had disease recurrence within the four month follow up period. |
| Mean Catheterization Time | After Surgery Completion, Up to 336 Hours | The average duration of the catheterization time was measured through study completion. |
| Mean Operative Time | After Surgery Completion, Up to 174 Minutes | The average operative time was measured through study completion. |
Countries
United States
Participant flow
Recruitment details
Participants were recruited between September 2012 and March 2017. Of the 95 participants who signed consent, 90 subjects began study participation.
Participants by arm
| Arm | Count |
|---|---|
| Monopolar Loop Electrocautery Participants completed a transurethral resection of the bladder tumor (TURBT) using monopolar loop electrocautery and all follow up procedures. | 41 |
| PK Button Vaporization Electrode Participants completed a transurethral resection of a bladder tumor using a PK button vaporization electrode and all follow up procedures. | 38 |
| Total | 79 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Withdrawal by Subject | 4 | 7 |
Baseline characteristics
| Characteristic | PK Button Vaporization Electrode | Monopolar Loop Electrocautery | Total |
|---|---|---|---|
| Age, Continuous | 69.2 years STANDARD_DEVIATION 11.4 | 68.7 years STANDARD_DEVIATION 12.2 | 69 years STANDARD_DEVIATION 11.7 |
| Race/Ethnicity, Customized Non-White | 7 Participants | 7 Participants | 14 Participants |
| Race/Ethnicity, Customized Unreported | 9 Participants | 10 Participants | 19 Participants |
| Race/Ethnicity, Customized White | 22 Participants | 24 Participants | 46 Participants |
| Region of Enrollment United States | 38 Participants | 41 Participants | 79 Participants |
| Sex: Female, Male Female | 8 Participants | 12 Participants | 20 Participants |
| Sex: Female, Male Male | 30 Participants | 29 Participants | 59 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 45 | 0 / 45 |
| other Total, other adverse events | 11 / 45 | 4 / 45 |
| serious Total, serious adverse events | 5 / 45 | 1 / 45 |
Outcome results
Number of Procedural Complications
The number of procedural complications describes the total number of post-operative bleeding, need for blood transfusion, bladder perforation, obturator nerve stimulation, catheterization time, or need for hospitalization or bladder irrigation events that occur within thirty days of the procedure.
Time frame: Post-Intervention (Up to 30 Days)
Population: Participants who completed all study procedures per protocol.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Monopolar Loop Electrocautery | Number of Procedural Complications | 23 complications |
| PK Button Vaporization Electrode | Number of Procedural Complications | 15 complications |
Mean Catheterization Time
The average duration of the catheterization time was measured through study completion.
Time frame: After Surgery Completion, Up to 336 Hours
Population: Participants who required catheterization after the operative procedure.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Monopolar Loop Electrocautery | Mean Catheterization Time | 46.7 hours | Standard Deviation 74.9 |
| PK Button Vaporization Electrode | Mean Catheterization Time | 45.9 hours | Standard Deviation 72.9 |
Mean Operative Time
The average operative time was measured through study completion.
Time frame: After Surgery Completion, Up to 174 Minutes
Population: Participants who completed all study procedures per protocol.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Monopolar Loop Electrocautery | Mean Operative Time | 46.0 minutes | Standard Deviation 28.7 |
| PK Button Vaporization Electrode | Mean Operative Time | 56.4 minutes | Standard Deviation 35.4 |
Number of Participants With Disease Recurrence
The number of participants who had disease recurrence within the four month follow up period.
Time frame: Post-Intervention (Up to 4 Months)
Population: Participants who completed all study procedures per protocol.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Monopolar Loop Electrocautery | Number of Participants With Disease Recurrence | 8 participants |
| PK Button Vaporization Electrode | Number of Participants With Disease Recurrence | 5 participants |